MoveMed

MoveMed is a digital biomarkers and therapeutics startup based in United Kingdom, aiming to revolutionize the clinical care and clinical trials for neuromuscular disease. The company's slogan "Turning every day interactions with mobile technology into clinical assessments" encapsulates its core mission. Leveraging patent pending technology, MoveMed focuses on precision measurement of movement through interactive games and background monitoring, enabling the production of high frequency metrics that can diagnose and monitor neuromuscular disease remotely and conveniently for patients. This innovation holds potential to transform outcomes and research in the field. While the founded date and last investment details are not available, MoveMed is actively seeking research, employment, product, or investment opportunities. With its focus on addressing critical medical needs through innovative technology, MoveMed presents an intriguing opportunity for potential investors and collaborators.